Tenderfy

EMBED 3.0 - Improvement of Formulations

Comprador
Cardiff University
Publicado
2026-10-19
Plazo
No indicado
Fuentes
UK_FTS
Valor
No indicado

Descripción

La descripción está en el idioma de la fuente.

The B&M Gates Foundation (funder) have reviewed the work with the EMBED research team, undertaken with the manufacturer ProMed, and have decided that to push the EMBED 3.0 project into its next stage (EMBED 4.0 – Human Trials), they’ll need to demonstrate their ability to vary the additional batches offer a more robust mechanism for the medications to enter patients. The additional work has been again funded by the foundation for the purpose of increasing the viability of the delivery method (technology developed as part of EMBED) - Previous direct award for the initial development via Regulation 41 - Schedule 5, para 2.

Suscripción

Consulte gratis el resumen de cada anuncio. Los enlaces al anuncio oficial y sus documentos, los permisos de construcción y el acceso MCP personal requieren una suscripción de pago activa.

Leer